Location History:
- Kodaira, JP (1988)
- Tokyo, JP (1992)
Company Filing History:
Years Active: 1988-1992
Title: Innovations by Inventor Mari Toji
Introduction
Mari Toji, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals. With a focus on developing innovative compounds, Toji has secured a total of two patents that enhance the efficacy of pharmaceutical compositions.
Latest Patents
Toji's latest patents revolve around derivatives of dihydroxybenzamide, which promise to facilitate advancements in pharmaceutical applications. The first patent discloses a specific derivative of dihydroxybenzamide, characterized by variations in the chemical structure, including options for straight-chain and branched-chain alkyl groups, as well as cyclo-alkyl and pyridyl groups. The formula defines these components in relation to their hydroxyl and amino functionalities, showcasing potential therapeutic applications. The second patent builds upon this foundation, further detailing a pharmaceutical composition that incorporates this derivative, thereby enhancing its potential use in medical treatments.
Career Highlights
Currently, Mari Toji is associated with Kureha Kagaku Kogyo Kabushiki Kaisha, a pioneer in fine chemicals and pharmaceuticals. Her work at this esteemed organization allows her to merge her inventive prowess with a commitment to advancing healthcare solutions. Toji's patents are a testament to her dedication to innovation in the pharmaceutical industry.
Collaborations
Throughout her career, Toji has collaborated with notable colleagues, including Hitoshi Takita and Sakuo Noda. Their collective expertise in research and development has undoubtedly contributed to the success of her patented inventions.
Conclusion
In summary, Mari Toji stands out as a key figure in the realm of pharmaceutical innovation. Her patented works promise to drive significant advancements in drug development, reflecting her commitment to creating effective solutions that address medical needs. Her journey continues to inspire and shape the future of pharmaceuticals in Japan and beyond.